Bumrungrad Competitors

Delisted . USA . 
Stock . Bumrungrad Hospital PCL
BUGDFDelisted Stock  USD 4.23  0.00  0.00%   
Bumrungrad Hospital PCL competes with Nihon Kohden, Ryman Healthcare, Ramsay Health, Amplifon SpA, and Medipal Holdings; as well as few others. The company classifies itself under null sector and is part of null industry. Analyzing Bumrungrad Hospital competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bumrungrad Hospital to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.

Bumrungrad Hospital vs Shandong Weigao Correlation

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bumrungrad Hospital's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
4.234.234.23
Details
Intrinsic
Valuation
LowRealHigh
4.024.024.65
Details
Naive
Forecast
LowNextHigh
4.464.464.46
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.134.194.25
Details

Bumrungrad Hospital Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bumrungrad Hospital and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Bumrungrad and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bumrungrad Hospital PCL does not affect the price movement of the other competitor.

High positive correlations

AMFPF
+ 0.74
NHNKY
MEPDF
+ 0.52
NHNKY
AMBFF
+ 0.51
AMFPF
AMBFF
+ 0.47
NHNKY
MAHLY
+ 0.46
RMYHY
MEPDF
+ 0.28
AMFPF
  

High negative correlations

SHWGY
- 0.67
MAHLY
MAHLY
- 0.46
AMFPF
AMBFF
- 0.4
RMYHY
SHWGY
- 0.31
MEPDF
AMBFF
- 0.21
MAHLY
SHWGY
- 0.2
RMYHY

Risk-Adjusted Indicators

There is a big difference between Bumrungrad Pink Sheet performing well and Bumrungrad Hospital Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bumrungrad Hospital's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NHNKY  3.18  0.10  0.00 (0.12) 4.66 
(3.58)
 8.10 
(9.26)
 30.18 
SDGCF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
RHCGF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
RMYHY  0.85  0.33  0.00 (5.40) 0.00 
 0.00 
 0.00 
 0.00 
 16.10 
AMFPF  0.59 (0.18) 0.00 (0.14) 0.00 
 0.00 
 0.00 
 0.00 
 12.28 
MAHLY  0.55  0.18  0.00 (1.33) 0.00 
 0.00 
 2.38 
(0.83)
 10.68 
MEPDF  0.47  0.17  0.00  0.26  0.00 
 0.00 
 0.00 
 0.00 
 15.15 
AMBFF  0.96 (0.27) 0.00 (5.75) 0.00 
 0.00 
 2.14 
(5.08)
 13.05 
SNPHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SHWGY  1.90 (0.25) 0.00  0.69  0.00 
 0.00 
 0.00 
(9.84)
 34.91 

Bumrungrad Hospital Competitive Analysis

The better you understand Bumrungrad Hospital competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bumrungrad Hospital's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bumrungrad Hospital's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BUGDF NHNKY RHCGF RMYHY AMFPF MAHLY MEPDF AMBFF SNPHF SHWGY
 0.00 
 4.23 
Bumrungrad
 1.46 
 11.81 
Nihon
 0.00 
 1.75 
Ryman
 0.00 
 6.24 
Ramsay
 0.00 
 16.49 
Amplifon
 0.00 
 18.00 
Medipal
 15.15 
 19.00 
MediPal
 0.00 
 12.90 
Ambu
 0.00 
 11.45 
Santen
 4.96 
 2.30 
Shandong
Market Volatility
(90 Days Market Risk)
Very steady
Slightly risky
Very steady
Somewhat reliable
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very risky
Market Performance
(90 Days Performance)
Weakest
Soft
Weakest
Good
Weakest
Fair
Fair
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Low
Small
Small
Low
Low
Low
Low
Hazard
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Under Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Hold
Strong Buy
Strong Buy
Sell
Strong Buy
Strong Sell
Not Rated
Strong Sell
Current Ratio
3.1
3.73
0.71
0.88
0.62
1.21
1.21
1.94
2.48
2.99
Net Asset
20.86 B
210.2 B
10.97 B
19.47 B
N/A
1.71 T
1.71 T
7.21 B
459.98 B
30.37 B
Profit Margin
0.21
0.0763
1.13
0.0202
0.0819
0.0091
0.0085
0.0209
-0.0303
0.18
EBITDA
2.76 B
37.76 B
788.44 M
1.51 B
397.61 M
61.86 B
71.64 B
492 M
53.91 B
2.98 B
Operating Margin
0.26
0.0945
-0.0225
0.0337
0.14
0.0138
0.0141
0.033
-0.0024
0.22
Current Valuation
4.63 B
1.58 B
4.01 B
17.18 B
11.47 B
1.21 B
1.24 B
3.73 B
2.6 B
6.75 B
Price To Book
9.22
1.64
1.08
3.93
N/A
0.67
0.76
5.1
1.39
2.18
Retained Earnings
N/A
83.97 B
1.28 B
1.18 B
365 M
N/A
N/A
N/A
230.22 B
7.93 B
Current Asset
N/A
100.09 B
221 M
1.84 B
339 M
N/A
N/A
N/A
156.63 B
8.26 B
Five Year Return
N/A
1.35
N/A
N/A
N/A
1.85
N/A
N/A
1.57
1.45
Beta
0.38
-0.12
0.79
0.58
0.81
0.26
0.26
0.59
0.38
0.4
Number Of Employees
40
5.64 K
6.8 K
88 K
18.6 K
12.8 K
12.8 K
4.5 K
4.32 K
11.48 K
Shares Outstanding
794.89 M
168.25 M
500 M
915.53 M
220.66 M
209.96 M
209.96 M
219.75 M
388.22 M
1.13 B
Cash Flow From Operations
3.56 B
25.7 B
585.98 M
715.5 M
462.37 M
61.22 B
61.22 B
95 M
46.04 B
3.04 B
Annual Yield
0.015
0.0191
0.0389
0.0142
N/A
0.0264
0.0267
0.0036
0.0319
0.0132
Total Debt
23.22 M
325 M
2.58 B
5.17 B
1.57 B
N/A
N/A
1.25 B
32.93 B
3.46 B
Return On Equity
0.23
0.0988
0.18
0.0836
0.19
0.0597
0.0561
0.0236
-0.0264
0.13
Z Score
N/A
3.6
N/A
1.2
2.8
1.0
1.0
1.8
N/A
1.2
Return On Asset
0.14
0.0598
-7.0E-4
0.0155
0.0521
0.0161
0.0169
0.0141
-0.001
0.0604
Book Value Per Share
22.74
958.31
7.26
4.04
4.55
2636.25
2628.87
16.22
780.63
18.04
Current Liabilities
N/A
33.24 B
107 M
1.99 B
271 M
N/A
N/A
N/A
50.32 B
2.36 B
Total Asset
20.86 B
210.2 B
10.97 B
19.47 B
1.33 B
1.71 T
1.71 T
7.21 B
459.98 B
30.37 B
Debt To Equity
0.004
0.002
0.76
2.36
1.61
0.045
0.045
0.36
0.097
0.2
Last Dividend Paid
3.2
40.0
0.22
N/A
0.26
46.0
46.0
N/A
16.0
0.15
Shares Owned By Institutions
5.92
0.071
26.4
N/A
33.14
N/A
27.34
36.2
53.5
N/A
Market Capitalization
5.14 B
2.12 B
2.08 B
10.86 B
4.75 B
2.76 B
2.79 B
3.84 B
2.95 B
7.69 B
Price To Earning
303.0
15.72
11.98
48.23
47.11
12.45
15.57
64.15
14.54
19.07
Price To Earnings To Growth
N/A
N/A
2.97
N/A
N/A
N/A
N/A
N/A
20398.6
N/A
Price To Sales
0.26
0.0099
4.64
0.72
2.95
8.0E-4
8.0E-4
0.8
0.0118
0.51
Net Income
1.22 B
23.43 B
692.87 M
274 M
157.78 M
29.42 B
29.42 B
93 M
27.22 B
2.24 B
Earnings Per Share
0.14
0.89
0.77
0.2
0.76
0.96
0.95
0.05
0.5
0.33
Shares Owned By Insiders
2.34
N/A
17.22
N/A
42.23
N/A
9.02
26.04
3.21
N/A
Revenue
12.46 B
205.13 B
503.76 M
13.08 B
2.11 B
3.29 T
3.29 T
4.44 B
266.26 B
13.15 B
Working Capital
N/A
66.85 B
114 M
(151 M)
68 M
N/A
N/A
N/A
106.3 B
5.9 B
Cash And Equivalents
6.33 B
54.54 B
47.88 M
325.5 M
162.44 M
237.6 B
237.6 B
126 M
69.53 B
7.15 B
Cash Per Share
7.96
324.25
0.1
0.36
0.73
N/A
N/A
0.5
176.84
6.26
Gross Profit
4.87 B
109.09 B
42.52 M
1.41 B
487.17 M
217.44 B
217.44 B
2.55 B
156.59 B
7.25 B
Day Typical Price
4.23
11.52
1.75
6.24
16.49
18.0
19.0
12.9
11.45
2.3
Accumulation Distribution
N/A
0.0737
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
0.87
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
0.1954
0.0
0.0
0.0
0.0
9.2 T
0.0
0.0
0
Period Momentum Indicator
N/A
0.17
N/A
N/A
N/A
N/A
2.5
N/A
N/A
(0.12)
Rate Of Daily Change
1.0
1.01
1.0
1.0
1.0
1.0
1.15
1.0
1.0
0.95
Day Median Price
4.23
11.38
1.75
6.24
16.49
18.0
19.0
12.9
11.45
2.3
Price Action Indicator
N/A
0.52
N/A
N/A
N/A
N/A
1.25
N/A
N/A
(0.06)
Relative Strength Index
5.69
54.71
N/A
88.16
46.51
68.47
100.0
34.58
100.0
38.01
Coefficient Of Variation
N/A
6174.31
N/A
663.17
(1,879)
732.86
793.73
(846.79)
N/A
(1,756)
Mean Deviation
N/A
3.18
N/A
0.8478
0.588
0.5485
0.4734
0.9611
N/A
1.9
Jensen Alpha
N/A
0.1036
N/A
0.3293
(0.18)
0.1784
0.1727
(0.27)
N/A
(0.25)
Total Risk Alpha
N/A
(0.36)
N/A
0.1291
(0.30)
0.0536
0.062
(0.45)
N/A
(0.70)
Sortino Ratio
N/A
6.0E-4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
24.59
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Standard Deviation
N/A
4.8
N/A
2.22
2.08
1.32
1.91
2.15
N/A
4.75
Kurtosis
N/A
2.92
N/A
15.13
22.11
20.59
63.0
11.03
N/A
9.42
Potential Upside
N/A
8.1
N/A
N/A
N/A
2.38
N/A
2.14
N/A
N/A
Treynor Ratio
N/A
(0.12)
N/A
(5.40)
(0.14)
(1.33)
0.2589
(5.75)
N/A
0.6916
Maximum Drawdown
N/A
30.18
N/A
16.1
12.28
10.68
15.15
13.05
N/A
34.91
Variance
N/A
23.02
N/A
4.95
4.31
1.74
3.64
4.62
N/A
22.58
Market Risk Adjusted Performance
N/A
(0.11)
N/A
(5.39)
(0.13)
(1.32)
0.2689
(5.74)
N/A
0.7016
Risk Adjusted Performance
N/A
0.0204
N/A
0.1176
(0.03)
0.1048
0.0988
(0.08)
N/A
(0.03)
Skewness
N/A
(0.15)
N/A
3.06
(2.99)
3.83
7.94
(2.23)
N/A
1.15
Semi Deviation
N/A
4.66
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Information Ratio
N/A
6.0E-4
N/A
0.1171
(0.09)
0.0797
0.0868
(0.15)
N/A
(0.07)
Value At Risk
N/A
(9.26)
N/A
N/A
N/A
(0.83)
N/A
(5.08)
N/A
(9.84)
Expected Short fall
N/A
(3.58)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
4.96
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
21.7
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Bumrungrad Hospital Competition Performance Charts

Five steps to successful analysis of Bumrungrad Hospital Competition

Bumrungrad Hospital's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bumrungrad Hospital PCL in relation to its competition. Bumrungrad Hospital's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bumrungrad Hospital in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bumrungrad Hospital's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bumrungrad Hospital PCL, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bumrungrad Hospital position

In addition to having Bumrungrad Hospital in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Municipals ETFs Thematic Idea Now

Broad Municipals ETFs
Broad Municipals ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Bumrungrad Pink Sheet

If you are still planning to invest in Bumrungrad Hospital PCL check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bumrungrad Hospital's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY